Detalhe da pesquisa
1.
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease.
Rheumatology (Oxford)
; 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039151
2.
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope.
Rheumatol Adv Pract
; 8(2): rkae056, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38765189
3.
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.
ERJ Open Res
; 10(1)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226064
4.
Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study.
BMJ Open Respir Res
; 10(1)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793682
5.
Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study.
ERJ Open Res
; 9(2)2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949962
6.
The barriers to accessing primary care resulting in hospital presentation for exacerbation of asthma or chronic obstructive pulmonary disease in a large teaching hospital in London.
Respir Med
; 117: 162-5, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27492527